Match Document Document Title
7612060 Triazoles and methods of use  
Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically...
7601837 Quinoline derivatives and their use as 5-HT6 ligands  
The present invention relates to novel quinoline compounds having pharmacological activity, to processes for their preparation, to compositions containing them and to their use in the treatment of...
7598250 Cyclic amine BACE-1 inhibitors having a heterocyclic substituent  
Disclosed are novel compounds of the formula or a pharmaceutically acceptable salt or solvate thereof, wherein R 1 is X is —O—, —C(R 14 ) 2 — or —N(R)—; Z is...
7598242 Compounds for the treatment of inflammatory disorders  
This invention relates to compounds of the Formula (I): or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions...
7582762 Salt and crystalline forms of (2R)-anti-5-{3-[4-(10,11-difluoromethanodibenzosuber-5-YL)piperazin-1-YL]-2-hydroxypropoxy}quinoline  
The present invention provides methods of treating leukemia comprising administration of a resistance modulating amount of a compound having the formula...
7582761 Vanilloid receptor ligands and their use in treatments  
Therapeutic benzimidazoles having the general structure: and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache,...
7582638 Pyrazole-isoquinoline urea derivatives as p38 kinase inhibitors  
The present invention provides kinase inhibitors of Formula (I) wherein R1, R2, and X are as described herein, or a pharmaceutically acceptable salt thereof.
7576086 Aralkyl-alcohol peiperazine derivatives and their uses as antidepressant  
Aryl alkanol piperazine derivatives of the formula and pharmaceutical compositions comprising the same. Also disclosed are methods for treating depression using the pharmaceutical composition....
7569563 Substituted quinolones II  
The invention relates to substituted quinolones of formula (I) and to methods for their preparation as well as their use for the production of medicaments for the treatment and/or prophylaxis of...
7560483 Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof  
The present invention provides a method for synthesizing 1-(acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require...
7550469 Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands  
The invention relates to heterocyclic substituted amide derivatives that display selective binding to dopamine D 3 receptors. In another aspect, the invention relates to a method for treating...
7541357 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin  
The compounds of the present invention are represented by the chemical structure found in Formula (I): wherein: the carbon atom designated * is in the R or S configuration; and X is a fused...
7531656 Synthesis of gatifloxacin  
Provided are a method for making (±)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methy l-1-piperazinyl)-4-oxo-3-quinolenecarboxylic acid, commonly known as gatifloxacin, in high purity, in a...
7531535 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors  
The present application describes lactam-containing compounds and derivatives thereof of Formula I: or pharmaceutically acceptable salt forms thereof, wherein ring P, if present is a 5-7...
7528135 Pyridine derivatives as H3 antagonists  
The present invention relates to compounds of formula I wherein R 1 , R 2 and A are as defined in the description and claims, and pharmaceutically acceptable salts thereof as well as to...
7507732 Cyclopentapyridine and tetrahydroquinoline derivatives  
6,7-Dihydro-5H-cyclopenta[b]pyridine and 5,6,7,8-tetrahydroquinoline compounds of Formula (I), including salts, hydrates and solvates thereof, that act as 5-HT 2 receptor ligands and their uses in...
7504504 Methods of preparing aripiprazole crystalline forms  
The invention encompasses aripiprazole crystalline forms, methods of preparing the same, and pharmaceutical compositions having aripiprazole crystalline forms.
7504400 MTP inhibiting aryl piperydines or piperazines substituted with 5-membered heterocycles  
The present invention is concerned with novel aryl piperidine or piperazine compounds substituted with certain 5-membered heterocycles having apoB secretion/MTP inhibiting activity and concomitant...
7501412 Isoquinoline compounds and medicinal use thereof  
The present invention relates to an isoquinoline compound represented by the following formula (I) or (II), an optically active form thereof, a pharmaceutically acceptable salt thereof, a water...
7491726 Crystalline forms of aripiprazole  
The present invention provides novel crystalline forms of aripiprazole and aripiprazole hydrochloride, processes for their preparation and pharmaceutical compositions containing them.
7482347 Piperazine derivatives with CCR-3 inhibiting activity  
Compounds of formula I in free or salt form, wherein Ar, R 1 , R 2 , R 3 , X and T have the meanings as indicated in the specification, are useful for treating a condition mediated by CCR-3,...
7476675 Quinolinone derivatives and uses thereof  
The invention provides compounds of the formula: and pharmaceutically acceptable salts or prodrugs thereof, wherein m, p, q, r, A, E, X, Y, R 1 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and are as...
7473692 Sulfonamide derivatives as D3-receptor ligands  
The present invention relates to new D 3 dopamine receptor subtype selectice ligands of formula (I) to pharmacological compositions containing the same and to their use in therapy and/or...
7468369 Sulfonyl pyrrolidines, method for producing the same and their use as drugs  
The invention relates to substituted sulfonylpyrrolidines of the formula I and to the physiologically tolerated salts thereof, as well as to their use as medicaments.
7465733 Piperazine compounds  
A compound selected from those of formula (I): wherein: R 1 , R 2 , R 3 and R 4 , which may be the same or different, each represent an atom or group selected from hydrogen, halogen,...
7459456 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors  
Compounds of formula (I) and pharmaceutically acceptable salts thereof are provided: wherein R 1 , m, X, R 2 , n, W, p, Y, Z, R 3 , R 4 , R 5 and q have the meanings as defined in the...
7456196 Bicyclic-substituted amines as histamine-3 receptor ligands  
Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising...
7456181 Aripiprazole crystalline forms  
The present invention provides novel crystalline forms of aripiprazole and processes for their preparation.
7456175 Piperazinyl-pyridine derivatives  
The present invention relates to compounds of formula I wherein R 1 , R 2 , X, Y, Z and m are as defined in the description and claims, and pharmaceutically acceptable salts thereof as well as...
7452888 Quinoline derivatives and their use as 5-ht6 ligands  
Disclosed are novel quinoline compounds of formula (I), processes for their preparation, compositions containing them and their use in the treatment of CNS disorders.
7452887 Quinoline- and isoquinoline-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof  
Quinoline- and isoquinoline-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, methods of using compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions...
7449477 7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (protein kinase B)  
The present invention relates to compounds Formula (I) as inhibitors of AKT activity, which are useful for the treatment of susceptible neoplasms and viral infections.
7442710 Substituted phenyl methanones  
The present invention relates to compounds of general formula IA or IB wherein X 1 and X 2 are each independently N or C—R″ and R 1 , R 2 ,R 3 , R 4 , R 5 , and R 6 are as defined in...
7439244 Quinoline compounds and pharmeceutical compositions containing them  
Disclosed are quinoline compounds of formula (I) having pharmacological activity, processes for their preparation, compositions containing them, and methods for the treatment of CNS and other...
7439243 Piperazinyl-quinoline derivatives useful for the treatment of CNS disorders  
Disclosed are quinoline compounds of formula (I) having pharmacological activity, processes for their preparation, compositions containing them, and methods for the treatment of CNS and other...
7432269 Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents  
The invention relates to compounds of the general formula (I): to the process for preparing them, and to the use thereof as a therapeutic agent having the property of being selective ligands...
7432264 Antimicrobial biaryl compounds  
Provided are antibacterial biaryl compounds having micromolar MIC activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain.
7429585 Phenyl-piperazine methanone derivatives, substituted by heterocyclic groups  
The present invention relates to compounds of the general formula IC wherein R 2 , R′, R″, R 3 , R 6 , X 1 and X 1 ′ are as defined herein and pharmaceutically active acid...
7414047 Piperazinyl and diazapanyl benzamides and benzthioamides  
Substituted piperazinyl and diazepanyl benzamides and benzthioamides of formula (I), compositions containing them, and methods of making and using them to treat histamine-mediated conditions.
7405217 N-aroyl piperazine derivatives as orexin receptor antagonists  
This invention relates to N-aroyl cyclic amino derivatives and their use as pharmaceuticals.
7402583 Substituted quinolines as antitumor agents  
The invention provides a compound of Formula (Ia), or a pharmaceutically acceptable salt thereof, a process for t he preparation of a compound of Formula (1 a ) and pharmaceutical compositions...
7396834 4(Phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders  
Compounds of general formula: wherein R 1 and R 2 are as defined in the specification, as well as salts, enantiomers thereof and pharmaceutical compositions including the compounds are prepared....
7388012 (Hydrazido)(amino)thiophene compounds  
Compounds represented by Formula (I): or a pharmaceutically acceptable salt or N-oxide thereof, wherein A and J are defined herein, are useful in the treatment of tumors and cancers such as...
7365077 Piperazine bis-amide derivatives and their use as antagonists of the orexin receptor  
Disclosed are piperazine bis-amide derivatives useful as antagonists of the orexin receptor and pharmaceutical compositions containing the same.
7351822 Serine protease inhibitors  
Compounds of formula (I) in which R 2 , X, Y, Cy, L and Lp(D) n have the meanings given in the specification, are inhibitors of the serine protease, Factor Xa and are useful in the treatment...
7332495 Aralkyl-ketone piperazine derivatives and their uses as new antalgic or ataractic agent  
Arylalkyl ketone piperazine derivatives of the formula: and pharmaceutical compositions comprising the same. Also disclosed are methods for using the compounds as analgesic and sedative agents....
7329749 Piperazinylcarbonylquinolines and -isoquinolines  
Compound of the formula (I) in which R 1 , R 2 and alk are as defined in Claim 1, are potent 5-HT 2A antagonist and are suitable for the treatment of psychoses, schizophrenia, depression,...
7326710 Aralkyl formyl-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent  
Aralkyl formyl alkyl piperazine derivatives Pharmaceutical compositions comprising the same, and methods of using them as a neuroprotective agent. Pharmaceutical results indicate that these...
7314879 Melanocortin receptor agonists  
The present invention relates to melanocortin receptor agonist of the formula (I): which is useful in the treatment for obesity, diabetes, and male and/or female sexual dysfunction
7312221 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same  
Inhibitors of MIF are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF...